Compare IHT & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IHT | ADXN |
|---|---|---|
| Founded | 1971 | 2002 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0M | 10.3M |
| IPO Year | N/A | N/A |
| Metric | IHT | ADXN |
|---|---|---|
| Price | $1.13 | $7.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 23.7K | 8.4K |
| Earning Date | 12-15-2025 | 12-04-2025 |
| Dividend Yield | ★ 1.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,443,699.00 | $198,824.00 |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.20 | $6.51 |
| 52 Week High | $4.24 | $12.05 |
| Indicator | IHT | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 28.04 | 43.39 |
| Support Level | $1.32 | $7.00 |
| Resistance Level | $1.30 | $8.49 |
| Average True Range (ATR) | 0.07 | 0.59 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 7.69 | 18.37 |
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.